NASDAQ : IART

Integra LifeSciences Holdings Corporation

$19.25 USD

-$0.6 (-3.02%)

Volume
922.82K
Average Volume
1.03M
Market Capitalization
$1.5B
P/E Ratio
-2.97
Dividend Yield
0.00%
Price Target
$19.00
Year High
$20.26
Year Low
$8.70
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$3.38
Company Overview

NASDAQ

Stuart Essig

Medical - Devices

Healthcare

IART

4427

US

USD

https://www.integralife.com

609 275 0500

457985208

0000917520

Liquidity Metrics

1.96

3.38

1.95

0.68

0.00

Sales & Valuation

$1.64B

0.91

1.42

-147.95

-0.13

Profitability

-$6.73

-$516.47M

-30.15%

-32.59%

-47.65%

-13.86%

P/E Metrics

-2.97

0.00

0.00

Analyst Price Target & Rating

$19.00

$25.00

$19.00

Sell

2/5

26 Analysts

1.32%

Poll Results

About Integra LifeSciences Holdings Corporation (NASDAQ:IART) Stock

Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical division offers a comprehensive range of neurosurgical and neuro-critical care products. This includes specialized equipment for tissue ablation, dural repair solutions, cerebral spinal fluid management systems, intracranial monitoring tools, and cranial stabilization devices. Additionally, this segment provides surgical headlamps, variou ... s instrumentation, and supports these offerings with asset management software, technical assistance, and after-market services. Integra also supplies an extensive catalog of approximately 40,000 surgical instrument designs, along with a wide selection of surgical and lighting products. Its clientele spans hospitals, surgical centers, and extends to dental, podiatry, and veterinary practices. The Tissue Technologies segment specializes in innovative regenerative technology products for the treatment of both acute and chronic wounds. It further provides surgical tissue repair solutions for a multitude of applications, such as hernia repair, peripheral nerve protection and regeneration, and tendon reconstruction. This encompasses a broad array of offerings for skin and wound repair, plastic and reconstructive surgery products, bone grafting materials, and specialized nerve and tendon repair products. Integra LifeSciences distributes its diverse product portfolio internationally, reaching markets throughout the United States, Europe, Asia Pacific, and other global regions. Distribution is managed directly through its dedicated sales forces and various other channels, serving a wide array of healthcare entities including hospitals, integrated health networks, group purchasing organizations, individual clinicians, surgery centers, and other healthcare providers. Founded in 1989, Integra LifeSciences Holdings Corporation is headquartered in Princeton, New Jersey.

Integra LifeSciences Holdings Corporation (IART) Soars to 52-Week High, Time to Cash Out?

2026-07-16 10:36:46

Integra (IART) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Integra LifeSciences to Host Second Quarter 2026 Financial Results Conference Call on July 29, 2026

2026-07-16 08:00:00

PRINCETON, N.J., July 16, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2026 financial results on Wednesday, July 29, 2026, prior to the market open.

IART Stock Surges 52.1% in a Year: What's Driving the Rally?

2026-07-15 13:05:20

Integra LifeSciences has climbed 52.1% in a year as growth across both segments, improved execution and transformation efforts continue to boost results.

Here's Why Integra LifeSciences (IART) is a Strong Value Stock

2026-07-09 10:41:37

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Integra (IART) Is Attractively Priced Despite Fast-paced Momentum

2026-07-09 09:56:51

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Integra (IART) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

IART or SONVY: Which Is the Better Value Stock Right Now?

2026-07-06 12:40:33

Investors looking for stocks in the Medical - Instruments sector might want to consider either Integra LifeSciences (IART) or SONOVA HOLDING (SONVY). But which of these two stocks is more attractive to value investors?

Integra LifeSciences Appoints Topaz Kirlew Chief Regulatory Officer

2026-07-02 08:30:00

Kirlew will lead Integra's global regulatory affairs organization as the company continues to strengthen quality, compliance, and execution. Kirlew will lead Integra's global regulatory affairs organization as the company continues to strengthen quality, compliance, and execution.

Integra Lifesciences Holdings Corp (IART) Shares Fall 4.2% -- What GF Score of 71 Tells Investors

2026-06-30 21:27:00

On June 30, 2026, Integra Lifesciences Holdings Corp (IART) shares fell 4.2% to $17.98, amid a 52-week trading range of $8.70 to $18.92. This decline comes desp

Frequently Asked Questions

What is the current Integra LifeSciences Holdings Corporation (IART) stock price?

Integra LifeSciences Holdings Corporation(NASDAQ:IART) stock price is $19.25 in the last trading session. During the trading session, IART stock reached the peak price of $20.26 while $8.7 was the lowest point it dropped to. The percentage change in IART stock occurred in the recent session was --3.02% while the dollar amount for the price change in IART stock was -$0.6.

IART's industry and sector of operation?

The NASDAQ listed IART is part of Medical - Devices industry that operates in the broader Healthcare sector.

Who are the executives of IART?

Christopher Ward | Senior Director of Investor Relations
Stuart Essig | CEO, President & Chairman
Teshtar Elavia | Corporate VP & Chief Technology Officer
Raymond D. Turner FAANS | Corporate Vice President & Chief Medical Officer
Harvinder Singh | Executive Vice President & President of International Business

How many employees does IART have?

Number of IART employees currently stands at 4427. IART operates from 1100 Campus Road, Princeton, NJ 08540, US.

Link for IART official website?

Official Website of IART is: https://www.integralife.com

How do I contact IART?

IART could be contacted at phone #609 275 0500 and can also be accessed through its website. IART operates from 1100 Campus Road, Princeton, NJ 08540, US.

How many shares of IART are traded daily?

The average number of IART shares traded daily for last 3 months was 1.03M.

What is the market cap of IART currently?

The market value of IART currently stands at $1.5B with its latest stock price at $19.25